CCNB1IP1P3

Across TCGA pan-cancer cohorts, CCNB1IP1P3 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated CCNB1IP1P3 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CCNB1IP1P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCNB1IP1P3 expression acts as an unfavorable survival marker, although some lineages such as CESC show a favorable association.

LIHC, COAD, and KIRP are the cancer types where CCNB1IP1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	II,III,IV	0.077	0.463	.002	54	view →
COAD	OS	Tertile	IV	0.257	0.679	.008	39	view →
KIRP	DFS	Tertile	IV	0.088	0.502	<.001	36	view →
CESC	DFS	Tertile	All	0.877	0.496	.008	30	view →
UCEC	DFS	Tertile	All	0.310	0.677	.017	18	view →
READ	DFS	Tertile	IV	0.141	0.671	<.001	18	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	18	view →
ESCA	OS	Tertile	IV	0.238	0.593	.021	12	view →
SARC	DFS	Tertile	All	0.234	0.523	.035	9	view →
ACC	OS	Tertile	II,III,IV	0.257	0.629	.027	6	view →
LGG	DFS	Tertile	All	0.645	0.851	.018	6	view →
LUAD	OS	Tertile	All	0.623	0.801	.018	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

CCNB1IP1P3–LIHC (DFS)

Open the LIHC breakdown →